Importantly, we identify an association between p-eIF2α and tumor growth pattern, WHO tumor type, and tumor cell proliferation with higher p-eIF2α levels in regions with invasive patterns compared to in situ growth, and highest of all in regions with the highly aggressive solid growth pattern (Fig. 1c–e; Table 1). The gene discussed is EIF2A; the disease is neoplasm.